1 Department of Public Health Sciences, Karolinska Institute, Stockholm, Sweden
2 Department of Occupational and Public Health Sciences, University of Gävle, Gävle, Sweden
3 Department of Health Sciences, The Swedish Red Cross University College, Stockholm, Sweden
4 Department of Public of Health Sciences, Faculty of Health Sciences, Victoria University, Kampala, Uganda
Intimate Partner Violence (IPV) and Human Immunodeficiency Virus and Acquired Immune Deficiency Syndrome (HIV/AIDS) occur as dual epidemics with gender dimensions. IPV sometimes result in lack of decision making autonomy over one’s own health and this may negatively affect uptake HIV testing services.
The study aimed to examine the association between exposure to IPV and HIV testing among women of reproductive age in Uganda.
The study is based on cross-sectional data from 2011 Uganda Demographic and Health Survey (UDHS). A sub-sample of 1705 ever-partnered women aged 15-49 who responded to the domestic violence module was examined in the study. Bivariate and multivariable (logistic regression) analyses were used to determine the association between exposure to IPV and HIV testing.
Up to 82.3% and 61.5% of the respondents were tested for HIV ever and in the past year, respectively. The prevalence of physical IPV and IPV of any form in the past year was 25.6% and 44% respectively. Exposure to physical IPV and emotional IPV in the past year was associated with HIV testing within the past year. In the multivariate analysis, exposure to physical IPV remained significantly associated with HIV testing within the past year (OR: 1.34; 95% CI: 1.03-1.73). Frequent access to newspapers remained a significant predictor of HIV testing uptake.
HIV testing in the past year is associated with exposure to IPV among women of reproductive age in Uganda. There is a need to include IPV as a part of global strategy to address HIV/AIDS.
open-access license: This is an open access article distributed under the terms of the Creative Commons Attribution 4.0 International Public License (CC-BY 4.0), a copy of which is available at: https://creativecommons.org/licenses/by/4.0/legalcode. This license permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
* Address correspondence to this author at the Department of Health Sciences, The Swedish Red Cross University College, Stockholm, Sweden; Tel: +46858751679; E-mail: email@example.com